Recent Company News

• 07:34 AM ET Mar 26, 2026
  

  BrainsWay completes additional $6M milestone-based investment in Neurolief ltd. following FDA approval of ProlivRx system for MDD ($13.86, 0.00)

• 07:32 AM ET Mar 20, 2026
  

  Anxiety Treatment Boom: GAD Therapies Poised for Multi-Billion Dollar Expansion

• 07:32 AM ET Mar 19, 2026
  

  BrainsWay completes $1M milestone investment into Axis Integrated Mental Health ($13.44, 0.00)

• 10:04 AM ET Mar 11, 2026
  

  StreetAccount Summary: Stocks reaching new 52-week highs/lows (77 total)

• 09:39 AM ET Mar 11, 2026
  

  Transcript Intelligence: Brainsway Q4 Earnings Themes ($12.71, 0.00)

• 09:39 AM ET Mar 11, 2026
  

  Transcript Intelligence: Brainsway Q4 Earnings Guidance ($12.71, 0.00)

• 09:39 AM ET Mar 11, 2026
  

  Transcript Intelligence: Brainsway Q4 Earnings Q&A ($12.71, 0.00)

• 07:33 AM ET Mar 11, 2026
  

  Brainsway reports Q4 EPS $0.07 vs FactSet $0.03 [3 est, $0.02-0.04] ($12.71, 0.00)

• 07:35 AM ET Mar 04, 2026
  

  BrainsWay notes data on SWIFT accelerated Deep TMS protocol ($11.59, 0.00)

• 07:35 AM ET Feb 19, 2026
  

  BrainsWay announces new minority-stake investment in Canadian provider, BrainStim Health Inc. ($26.04, 0.00)